Acadia Pharmaceuticals buy Citigroup Inc.
Start price
09.05.24
/
50%
€14.59
Target price
09.05.25
€27.83
Performance (%)
17.44%
Price
25.07.24
€17.14
Summary
This prediction is currently active. The prediction currently has a performance of 17.44%. This prediction currently runs until 09.05.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 3.817% | 3.817% |
| iShares Core DAX® | 0.039% | 0.567% |
| iShares Nasdaq 100 | -4.018% | -5.554% |
| iShares Nikkei 225® | -2.389% | -1.434% |
| iShares S&P 500 | -2.115% | -2.351% |
Comments by Citigroup_Inc_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Citigroup Inc. from $30.19 to $30.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
13.12.23
13.12.23
€35.17
13.12.24
13.12.24
-14.33%
25.07.24
25.07.24
